174 related articles for article (PubMed ID: 37436451)
21. A nomogram incorporating six easily obtained parameters to discriminate intrahepatic cholangiocarcinoma and hepatocellular carcinoma.
Wang M; Gao Y; Feng H; Warner E; An M; Jia J; Chen S; Fang M; Ji J; Gu X; Gao C
Cancer Med; 2018 Mar; 7(3):646-654. PubMed ID: 29473340
[TBL] [Abstract][Full Text] [Related]
22. A Nomogram Based on Contrast-Enhanced Ultrasound to Predict the Microvascular Invasion in Hepatocellular Carcinoma.
Bo J; Xiang F; XiaoWei F; LianHua Z; ShiChun L; YuKun L
Ultrasound Med Biol; 2023 Jul; 49(7):1561-1568. PubMed ID: 37003955
[TBL] [Abstract][Full Text] [Related]
23. Potential diagnostic performance of contrast-enhanced ultrasound and tumor markers in differentiating combined hepatocellular-cholangiocarcinoma from hepatocellular carcinoma and cholangiocarcinoma.
Huang XW; Huang Y; Chen LD; Wang Z; Yang Z; Liu JY; Xie XY; Lu MD; Shen SL; Wang W
J Med Ultrason (2001); 2018 Apr; 45(2):231-241. PubMed ID: 29052791
[TBL] [Abstract][Full Text] [Related]
24. Contrast-enhanced ultrasound (CEUS) for differentiating between hepatocellular and cholangiocellular carcinoma.
Bohle W; Clemens PU; Heubach T; Zoller WG
Ultraschall Med; 2012 Dec; 33(7):E191-E195. PubMed ID: 22194045
[TBL] [Abstract][Full Text] [Related]
25. Utility of mean platelet volume in differentiating intrahepatic cholangiocarcinoma from hepatocellular carcinoma.
Zhang X; Huang WJ; Zhang ML; Wang W; Niu Y; Wang RT; Liu ZY
BMC Gastroenterol; 2022 Jun; 22(1):288. PubMed ID: 35668355
[TBL] [Abstract][Full Text] [Related]
26. Differentiation of mass-forming intrahepatic cholangiocarcinoma from poorly differentiated hepatocellular carcinoma: based on the multivariate analysis of contrast-enhanced computed tomography findings.
Zhao YJ; Chen WX; Wu DS; Zhang WY; Zheng LR
Abdom Radiol (NY); 2016 May; 41(5):978-89. PubMed ID: 27193795
[TBL] [Abstract][Full Text] [Related]
27. Added-value of ancillary imaging features for differentiating hepatocellular carcinoma from intrahepatic mass-forming cholangiocarcinoma on Gd-BOPTA-enhanced MRI in LI-RADS M.
Zheng W; Huang H; She D; Xiong M; Chen X; Lin X; Cao D
Abdom Radiol (NY); 2022 Mar; 47(3):957-968. PubMed ID: 34964069
[TBL] [Abstract][Full Text] [Related]
28. Diagnostic performance of magnetic resonance imaging and contrast-enhanced ultrasound in differentiating intrahepatic cholangiocarcinoma from hepatocellular carcinoma: a meta-analysis.
Wu Y; Xia C; Chen J; Qin Q; Ye Z; Song B
Abdom Radiol (NY); 2024 Jan; 49(1):34-48. PubMed ID: 37823913
[TBL] [Abstract][Full Text] [Related]
29. Differential diagnosis of hepatocellular carcinoma and intrahepatic cholangiocarcinoma based on spatial and channel attention mechanisms.
Huang JL; Sun Y; Wu ZH; Zhu HJ; Xia GJ; Zhu XS; Wu JH; Zhang KH
J Cancer Res Clin Oncol; 2023 Sep; 149(12):10161-10168. PubMed ID: 37268850
[TBL] [Abstract][Full Text] [Related]
30. The Degree of Contrast Washout on Contrast-Enhanced Ultrasound in Distinguishing Intrahepatic Cholangiocarcinoma from Hepatocellular Carcinoma.
Han J; Liu Y; Han F; Li Q; Yan C; Zheng W; Wang J; Guo Z; Wang J; Li A; Zhou J
Ultrasound Med Biol; 2015 Dec; 41(12):3088-95. PubMed ID: 26386477
[TBL] [Abstract][Full Text] [Related]
31. Differentiation between hepatocellular carcinoma and intrahepatic cholangiocarcinoma using contrast-enhanced ultrasound: A systematic review and meta-analysis.
Chen Y; Zhu Y; Chen K; Wang H; Zhang W; Bao J; Wang W
Clin Hemorheol Microcirc; 2021; 79(2):293-309. PubMed ID: 33935070
[TBL] [Abstract][Full Text] [Related]
32. Predictive factors of microvascular invasion in patients with intrahepatic mass-forming cholangiocarcinoma based on magnetic resonance images.
Chen S; Wan L; Zhao R; Peng W; Li Z; Zou S; Zhang H
Abdom Radiol (NY); 2023 Apr; 48(4):1306-1319. PubMed ID: 36872324
[TBL] [Abstract][Full Text] [Related]
33. Contrast ultrasound LI-RADS LR-5 identifies hepatocellular carcinoma in cirrhosis in a multicenter restropective study of 1,006 nodules.
Terzi E; Iavarone M; Pompili M; Veronese L; Cabibbo G; Fraquelli M; Riccardi L; De Bonis L; Sangiovanni A; Leoni S; Zocco MA; Rossi S; Alessi N; Wilson SR; Piscaglia F;
J Hepatol; 2018 Mar; 68(3):485-492. PubMed ID: 29133247
[TBL] [Abstract][Full Text] [Related]
34. Added value of ancillary imaging features for differentiating scirrhous hepatocellular carcinoma from intrahepatic cholangiocarcinoma on gadoxetic acid-enhanced MR imaging.
Choi SY; Kim YK; Min JH; Kang TW; Jeong WK; Ahn S; Won H
Eur Radiol; 2018 Jun; 28(6):2549-2560. PubMed ID: 29335868
[TBL] [Abstract][Full Text] [Related]
35. A nomogram to predict lymph node metastasis before resection in intrahepatic cholangiocarcinoma.
Meng ZW; Lin XQ; Zhu JH; Han SH; Chen YL
J Surg Res; 2018 Jun; 226():56-63. PubMed ID: 29661289
[TBL] [Abstract][Full Text] [Related]
36. Development and Comparison of Prediction Models Based on Sonovue- and Sonazoid-Enhanced Ultrasound for Pathologic Grade and Microvascular Invasion in Hepatocellular Carcinoma.
Zhang R; Li D; Chen Y; Xu W; Zhou W; Lin M; Xie X; Xu M
Ultrasound Med Biol; 2024 Mar; 50(3):414-424. PubMed ID: 38155069
[TBL] [Abstract][Full Text] [Related]
37. A multi-center diagnostic system for intrahepatic mass-forming cholangiocarcinoma based on preoperative MRI and clinical features.
Sheng R; Zhang Y; Wang H; Zhang W; Jin K; Sun W; Dai Y; Zhou J; Zeng M
Eur Radiol; 2024 Jan; 34(1):548-559. PubMed ID: 37552257
[TBL] [Abstract][Full Text] [Related]
38. Optimizing CT and MRI criteria for differentiating intrahepatic mass-forming cholangiocarcinoma and hepatocellular carcinoma.
Wu H; Liang Y; Wang Z; Tan C; Yang R; Wei X; Jiang X
Acta Radiol; 2023 Mar; 64(3):926-935. PubMed ID: 35898164
[TBL] [Abstract][Full Text] [Related]
39. Prediction of Microvascular Invasion in Combined Hepatocellular-Cholangiocarcinoma Based on Pre-operative Clinical Data and Contrast-Enhanced Ultrasound Characteristics.
Chen Y; Lu Q; Zhu Y; Huang B; Dong Y; Wang W
Ultrasound Med Biol; 2022 Jul; 48(7):1190-1201. PubMed ID: 35397928
[TBL] [Abstract][Full Text] [Related]
40. Imaging features of hepatocellular carcinoma compared to intrahepatic cholangiocarcinoma and combined tumor on MRI using liver imaging and data system (LI-RADS) version 2014.
Horvat N; Nikolovski I; Long N; Gerst S; Zheng J; Pak LM; Simpson A; Zheng J; Capanu M; Jarnagin WR; Mannelli L; Do RKG
Abdom Radiol (NY); 2018 Jan; 43(1):169-178. PubMed ID: 28765978
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]